DROPPING TODAY Biotechnology $494M Cap Quant: HOLD

Why Is Regenxbio Inc. (RGNX) Stock Down Today?

Updated Nov 16, 2026 8:30 PM ET · Prev Close $7.64

Pro Workspace
Last Session Price
$7.47 -2.23%
-$0.17 vs $7.64 prior close
Intraday Range
$7.42 – $7.82
Open $7.59
Relative Volume
0.32x Avg
399,035 sh
52-Week Range
$5.46 – $16.19
Benchmark Alpha
-0.34% vs SPY
+0.19% vs QQQ
20-Session Trend +1.0%

Primary Move Catalyst & Conviction

65% Signal Conviction
SECTOR 65% Driver Weight

Biotechnology & Biological Products sector moving together

This appears to be a sector-wide move. The Biotechnology & Biological Products sector is down 3.2% on average.

Volume Confirmation
LOW VOLUME (0.32x) Unconfirmed
Sub-average participation — monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 65%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

RGNX trading in line with the S&P 500 (-0.34% alpha)
RGNX Session
-2.23%
$7.47
S&P 500 (SPY)
-1.89%
$740.11
Nasdaq 100 (QQQ)
-2.42%
$663.44
Healthcare (XLV)
-0.38%
$188.14
Alpha vs SPY: -0.34% Alpha vs QQQ: +0.19% Alpha vs XLV: -1.85%
Peer Group: Biotechnology & Biological Products (-3.2% avg) Outperforming peers by +1.0%

Options Flow & Execution Desk

Bullish Flow · P/C 0.4
Call Volume
11,013
Contracts
Put Volume
4,454
Contracts
Put / Call Ratio
0.4
15,467 total vol
Implied Volatility
201.6%
Chain avg IV

Recent RGNX Catalyst Headlines

Verified Wire
Regenxbio Q3 Earnings Call Highlights

Regenxbio Nasdaq Rgnx is approaching pivotal trial results for its eye disease gene therapy and preparing a U.S. application for its Duchenne muscular dystrophy treatment, executives said during the company s third-quart

Yahoo Finance · Nov 06, 2026

1–3 Day Expected Range & Key Level

45% Follow-Through
Lower Bound
$7.25
Short-term support band
Upper Bound
$7.62
Short-term resistance band
Key Inflection Level
$7.10 (support)

Watch for breakdown below $7.47

Technical Regime (RGNX)

MIXED MA TREND
RSI (14)
48.3
Bearish
20-Day SMA
$7.42
Above 20d
50-Day SMA
$7.63
Below 50d
MACD Signal
Bullish
MACD 0.05
ADX (14)
14.5
Weak trend
10d Momentum
+0.31
Positive 10-day momentum

1-Year Historical Move Analogs

64 Events

Sessions in the past year where RGNX moved >3.0% down:

Continuation Rate
48.4%
31/64 sessions
Avg Next-Day Move
-0.76%
T+1 session return
Last analog: Nov 13, 2026 (-4.9%) → Next session: -2.2%

Retail & Crowd Sentiment

Neutral
24h Messages
0
7d avg 0.0
Bullish / Bearish
0.0% / 0.0%
None buzz
Crowd Discussion Digest

Bearish sentiment on $RGNX is growing as the company's expenses outpace revenues according to a StockTwits user.

Reddit communities: 1 comment (Neutral)

About Regenxbio Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), ...

Sector
Healthcare
Market Cap
$494M
Employees
353

Get Instant RGNX Catalyst Alerts

Receive an email alert when RGNX triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

RGNX Session & Catalyst FAQ

Why is RGNX stock down today?

This appears to be a sector-wide move. The Biotechnology & Biological Products sector is down 3.2% on average.

Is RGNX stock a buy or sell right now?

Today's session carries a 65% catalyst conviction score on 0.32x relative volume (low participation). Our multi-factor model currently rates RGNX as HOLD. Review full valuation, quality, and timing signals on the RGNX Buy or Sell Decision Brief →

What is RGNX's intrinsic value and expected trading range?

At $7.47, RGNX's modeled 1-to-3 session range is $7.25 – $7.62, with a key inflection level at $7.10 (support). Compare current price against multi-year cash flow projections in the RGNX Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for RGNX?

RSI at 48.3 reflects soft below-midline momentum. RGNX trades at $7.47 relative to its 20-day SMA ($7.42) and 50-day SMA ($7.63), reflecting a mixed moving-average structure.

Tradestie Flagship Research & Market Hubs